发明公开
EP0432479A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin 失效
Wasserfreie Arzneizubereitungen und Dosierformen zur rektalen Verabreichung von calcitonin。

  • 专利标题: Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin
  • 专利标题(中): Wasserfreie Arzneizubereitungen und Dosierformen zur rektalen Verabreichung von calcitonin。
  • 申请号: EP90121670.5
    申请日: 1990-11-13
  • 公开(公告)号: EP0432479A1
    公开(公告)日: 1991-06-19
  • 发明人: Lattanzi, FilippoVanni, Riccardo
  • 申请人: SCLAVO S.p.A.
  • 申请人地址: Via Fiorentina 1 I-53100 Siena IT
  • 专利权人: SCLAVO S.p.A.
  • 当前专利权人: SCLAVO S.p.A.
  • 当前专利权人地址: Via Fiorentina 1 I-53100 Siena IT
  • 代理机构: Gervasi, Gemma, Dr.
  • 优先权: IT2241089 19891116
  • 主分类号: A61K9/48
  • IPC分类号: A61K9/48 A61K9/66 A61K47/10 A61K37/30
Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin
摘要:
New formulations are described containing a calcitonin as active principle and suitable for rectal administration in the form of soft gelatin capsules, in which the active principle, possibly mixed with a stabilizer, is dispersed in a liquid vehicle consisting of a polyethyleneglycol or a mixture of polyethyleneglycols of different molecular weight which has the consistency of a homogeneous fluid at ambient temperature, and possibly a C₂-C₆ alcohol with at least 2 hydroxyl groups, and present in a weight quantity of less than 15%. Said formulations, which contain no absorption adjuvant, enable the same pattern of hematic levels to be obtained as obtainable by conventional intramuscular administration, for equal unit dosages. Moreover, the absence of water makes said formulations highly stable.
信息查询
0/0